|Articles|October 14, 2019
Quantifying Quality Attributes of AAV Gene Therapy Vectors by SEC-UV-MALS-dRI
Author(s)Wyatt
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Formulation Strategies, Tech Advances, Challenges, and Considerations in Novel Drug Delivery
2
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
3
Drug Digest: Biopharma Landscape Evolves Through Strategic Alliances and Technology Integration
4
FAQ: What You Need to Know About How Industry is Tackling CGT Bottlenecks
5
